
Danh C. Le
Examiner (ID: 4012, Phone: (571)272-7868 , Office: P/2642 )
| Most Active Art Unit | 2642 |
| Art Unit(s) | 2617, 2683, 2642 |
| Total Applications | 1823 |
| Issued Applications | 1615 |
| Pending Applications | 72 |
| Abandoned Applications | 144 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19430120
[patent_doc_number] => 20240298618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => UT2 GENE-DEFICIENT MOUSE MODEL AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR MYELOID LEUKEMIA, USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/654005
[patent_app_country] => US
[patent_app_date] => 2024-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/654005 | UT2 GENE-DEFICIENT MOUSE MODEL AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR MYELOID LEUKEMIA, USING SAME | May 2, 2024 | Pending |
Array
(
[id] => 20492646
[patent_doc_number] => 12534509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Engineered immune cells with receptor cross-talk
[patent_app_type] => utility
[patent_app_number] => 18/629423
[patent_app_country] => US
[patent_app_date] => 2024-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 31039
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18629423
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/629423 | Engineered immune cells with receptor cross-talk | Apr 7, 2024 | Issued |
Array
(
[id] => 19331176
[patent_doc_number] => 20240245606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-25
[patent_title] => SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE
[patent_app_type] => utility
[patent_app_number] => 18/425997
[patent_app_country] => US
[patent_app_date] => 2024-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18425997
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/425997 | SDC-2 EXOSOME COMPOSITIONS AND METHODS OF ISOLATION AND USE | Jan 28, 2024 | Pending |
Array
(
[id] => 19554944
[patent_doc_number] => 20240366736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => METHOD FOR MANAGING PAIN
[patent_app_type] => utility
[patent_app_number] => 18/418736
[patent_app_country] => US
[patent_app_date] => 2024-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18418736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/418736 | METHOD FOR MANAGING PAIN | Jan 21, 2024 | Pending |
Array
(
[id] => 19300401
[patent_doc_number] => 20240228970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => METHODS AND SYSTEMS FOR THE SCALABLE GROWTH AND MAINTENANCE OF STEM CELLS USING OPTOGENETICS IN SUSPENSION
[patent_app_type] => utility
[patent_app_number] => 18/417480
[patent_app_country] => US
[patent_app_date] => 2024-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417480
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/417480 | METHODS AND SYSTEMS FOR THE SCALABLE GROWTH AND MAINTENANCE OF STEM CELLS USING OPTOGENETICS IN SUSPENSION | Jan 18, 2024 | Pending |
Array
(
[id] => 19234062
[patent_doc_number] => 20240191254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => TRANSGENE CASSETTES DESIGNED TO EXPRESS A HUMAN MECP2 GENE
[patent_app_type] => utility
[patent_app_number] => 18/411647
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411647
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411647 | Transgene cassettes designed to express a human MECP2 gene | Jan 11, 2024 | Issued |
Array
(
[id] => 20848285
[patent_doc_number] => 12685297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Genetically modified mouse, methods for producing the same, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 18/397846
[patent_app_country] => US
[patent_app_date] => 2023-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3398
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397846
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/397846 | GENETICALLY MODIFIED MOUSE, METHODS FOR PRODUCING THE SAME, AND USES THEREOF | Dec 26, 2023 | Pending |
Array
(
[id] => 19226882
[patent_doc_number] => 12006516
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Differentiation of pancreatic endocrine cells
[patent_app_type] => utility
[patent_app_number] => 18/391799
[patent_app_country] => US
[patent_app_date] => 2023-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 16
[patent_no_of_words] => 60461
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18391799
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/391799 | Differentiation of pancreatic endocrine cells | Dec 20, 2023 | Issued |
Array
(
[id] => 19265683
[patent_doc_number] => 20240209382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/516243
[patent_app_country] => US
[patent_app_date] => 2023-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18516243
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/516243 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | Nov 20, 2023 | Pending |
Array
(
[id] => 19186244
[patent_doc_number] => 20240165157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/382284
[patent_app_country] => US
[patent_app_date] => 2023-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18382284
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/382284 | Compositions and methods for treating cancer | Oct 19, 2023 | Issued |
Array
(
[id] => 18842780
[patent_doc_number] => 20230405184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => SYSTEM AND METHODS FOR HARVESTING AND PROCESSING PERIOSTEUM FIBERS
[patent_app_type] => utility
[patent_app_number] => 18/238773
[patent_app_country] => US
[patent_app_date] => 2023-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18238773
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/238773 | SYSTEM AND METHODS FOR HARVESTING AND PROCESSING PERIOSTEUM FIBERS | Aug 27, 2023 | Pending |
Array
(
[id] => 19020444
[patent_doc_number] => 20240076615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => MODELS AND METHODS FOR RAPID SCREENING OF THE EFFICACY OF IMMUNOREGULATING DRUGS
[patent_app_type] => utility
[patent_app_number] => 18/238509
[patent_app_country] => US
[patent_app_date] => 2023-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9948
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18238509
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/238509 | MODELS AND METHODS FOR RAPID SCREENING OF THE EFFICACY OF IMMUNOREGULATING DRUGS | Aug 26, 2023 | Abandoned |
Array
(
[id] => 18862242
[patent_doc_number] => 20230416678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => CELL CULTURE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 18/361233
[patent_app_country] => US
[patent_app_date] => 2023-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18361233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/361233 | CELL CULTURE MEDIUM | Jul 27, 2023 | Abandoned |
Array
(
[id] => 19098077
[patent_doc_number] => 20240117305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => THREE-DIMENSIONAL PRINTABLE BIOCOMPATIBLE PHOTOPOLYMERIZABLE INK WITH SPATIALLY CONTROLLED DUAL PROTEIN MOTIFS FOR CO-CULTURE FUNCTIONALITY
[patent_app_type] => utility
[patent_app_number] => 18/216337
[patent_app_country] => US
[patent_app_date] => 2023-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18216337
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/216337 | THREE-DIMENSIONAL PRINTABLE BIOCOMPATIBLE PHOTOPOLYMERIZABLE INK WITH SPATIALLY CONTROLLED DUAL PROTEIN MOTIFS FOR CO-CULTURE FUNCTIONALITY | Jun 28, 2023 | Pending |
Array
(
[id] => 18771125
[patent_doc_number] => 20230365935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => STABILIZED AMORPHOUS CALCIUM CARBONATE AS A SUPPLEMENT FOR CELL CULTURE MEDIA
[patent_app_type] => utility
[patent_app_number] => 18/200938
[patent_app_country] => US
[patent_app_date] => 2023-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18200938
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/200938 | STABILIZED AMORPHOUS CALCIUM CARBONATE AS A SUPPLEMENT FOR CELL CULTURE MEDIA | May 22, 2023 | Pending |
Array
(
[id] => 18923317
[patent_doc_number] => 20240026321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-25
[patent_title] => CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/313914
[patent_app_country] => US
[patent_app_date] => 2023-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18313914
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/313914 | CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF | May 7, 2023 | Pending |
Array
(
[id] => 18879437
[patent_doc_number] => 20240002806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHOD FOR DIFFERENTIATING ADULT STEM CELLS INTO FINAL TISSUE
[patent_app_type] => utility
[patent_app_number] => 18/119314
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119314
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/119314 | METHOD FOR DIFFERENTIATING ADULT STEM CELLS INTO FINAL TISSUE | Mar 8, 2023 | Abandoned |
Array
(
[id] => 18612647
[patent_doc_number] => 20230279379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHODS AND MICROFLUIDIC DEVICE FOR PRODUCING EXTRACELLULAR VESICLES
[patent_app_type] => utility
[patent_app_number] => 18/178736
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12533
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18178736
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/178736 | METHODS AND MICROFLUIDIC DEVICE FOR PRODUCING EXTRACELLULAR VESICLES | Mar 5, 2023 | Pending |
Array
(
[id] => 20057359
[patent_doc_number] => 20250195581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => CELL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/848627
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3394
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18848627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/848627 | CELL PREPARATION | Mar 1, 2023 | Pending |
Array
(
[id] => 18552384
[patent_doc_number] => 20230250393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => PRE-TREATING CARDIOMYOCYTES WITH ANTI-ARRHYTHMIC DRUGS TO REDUCE ENGRAFTMENT ARRHYTHMIA
[patent_app_type] => utility
[patent_app_number] => 18/099419
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18099419
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/099419 | PRE-TREATING CARDIOMYOCYTES WITH ANTI-ARRHYTHMIC DRUGS TO REDUCE ENGRAFTMENT ARRHYTHMIA | Jan 19, 2023 | Abandoned |